A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings

AUTOR(ES)

Nagasaka, Yosuke

FONTE

National Academy of Sciences

RESUMO

Alzheimer's disease (AD) is a neurodegenerative disease with an insidious onset and progressive course that inevitably leads to death. The current diagnostic tools do not allow for diagnosis until the disease has lead to irreversible brain damage. Genetic studies of autosomal dominant early onset familial AD has identified three causative genes: amyloid precursor protein (APP), presenilin 1 and 2 (PSEN1 and PSEN2). We performed a global gene expression analysis on fibroblasts from 33 individuals (both healthy and demented mutation carriers as well as wild-type siblings) from three families segregating the APPSWE, APPARC and PSEN1 H163Y mutations, respectively. The mutations cause hereditary progressive cognitive disorder, including typical autosomal dominant AD. Our data show that the mutation carriers share a common gene expression profile significantly different from that of their wild-type siblings. The results indicate that the disease process starts several decades before the onset of cognitive decline, suggesting that presymptomatic diagnosis of AD and other progressive cognitive disorders may be feasible in the near future.

Documentos Relacionados

• Expression cDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product.
• Interferon-induced gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cells.
• Expression of the ogt gene in wild-type and ada mutants of E. coli.
• Structure and Expression of Wild-Type and Suppressible Alleles of the Drosophila Purple Gene
• Differential gene expression between wild-type and Gulo-deficient mice supplied with vitamin C